As of September 2026, 859 paid clinical trials are recruiting in New Haven, Connecticut. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
New Haven offers studies at sites including Yale University for conditions such as Advanced Solid Tumor, Breast Cancer, Alcohol Use Disorder, Acute Myeloid Leukemia. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in New Haven, CT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Yale University | Acute Myeloid Leukemia, Alcohol Use Disorder, Anatomic Stage II Breast Cancer AJCC v8 | 248 |
| Yale Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, Breast Cancer | 69 |
| Yale New Haven Hospital | Ischemic Stroke, Multiple Myeloma, NAFLD | 65 |
| Yale University School of Medicine | Alzheimers Disease, Alzheimers Disease, Familial, Colorectal Cancer | 62 |
| Yale School of Medicine | Epilepsy, Epilepsy (Treatment Refractory), Adolescent Mental Health | 38 |
| Smilow Cancer Center/Yale-New Haven Hospital | Ovarian Carcinoma, Plasma Cell Myeloma, Advanced Hepatocellular Carcinoma | 20 |
| Yale | AML, MDS, Acute Gastrointestinal Bleeding | 13 |
| Connecticut Mental Health Center | Borderline Personality Disorder, Alcohol Use, Alcohol Use Disorder | 11 |
| Yale-New Haven Hospital | Acute Ischemic Stroke, Acute Myeloid Leukemia, Anemia, Sickle Cell | 10 |
| GSK Investigational Site | HIV Infections, Colonic Neoplasms, Gastrointestinal Neoplasms | 8 |
| Smilow Cancer Hospital at Yale New Haven | Advanced Solid Tumor, AML, AML With Mutated NPM1 | 7 |
| Yale Child Study Center | Speech, Anxiety Disorder of Adolescence, Autism | 7 |
| Yale New Haven Health | Chronic Kidney Diseases, Claudication, Critical Limb Ischemia | 7 |
| Yale New Haven Health System | Aortic Stenosis, Heart Failure, ATTR Amyloidosis With Cardiomyopathy | 6 |
| Yale University, Yale Cancer Center | Endometrial Cancer, Ovarian Cancer, Acute Myelogenous Leukemia | 6 |
| BLOOM | COVID-19, Mental Health Issue | 5 |
| Musical Intervention Studios | COVID-19, Mental Health Issue | 5 |
| Smilow Cancer Hospital | Cancer, Sickle Cell Disease, Hemoglobinopathies | 5 |
| Yale New Haven Children's Hospital | Antibiotic Stewardship, Failed or Difficult Intubation, Sequela, Intubation Complication | 5 |
| Yale University Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, Anal Squamous Cell Carcinoma | 5 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, Generalized Myasthenia Gravis | 4 |
| Institute for Neurodegenerative Disorders | Healthy Control Subjects, Parkinson's Disease, Parkinson's Disease (PD) | 4 |
| Smilow Cancer Hospital - Yale New Haven Health | Esophageal Cancer, Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Solid Tumors | 4 |
| Yale University Yale Cancer Center | Advanced Solid Tumor, Advanced Solid Tumors, B Cell Lymphoma | 4 |
| Yale-New Haven Hospital-Yale Cancer Center | Advanced Breast Cancer, Breast Cancer, CRC | 4 |
Recruiting trials in New Haven grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 859 recruiting clinical trials in New Haven, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in New Haven compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in New Haven include Advanced Solid Tumor (22), Breast Cancer (19), Alcohol Use Disorder (15), Acute Myeloid Leukemia (13), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Haven on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in New Haven include Yale University, Yale Cancer Center, Yale New Haven Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in New Haven are Cancer & tumors (318), Neurology & pain (42), Cardiovascular (38). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.